For the first time, scientists at Newcastle University, UK, have identified changes in the DNA of the tumour cells in those with CYLD cutaneous syndrome (CCS) that may help them grow.
A study published in Nature Communications suggest that the tumour cells gain a ‘survival advantage’ when the changes occur — an important step in understanding ways to develop treatments.
Gene discovery
CCS is a hereditary condition that affects areas of the body where there are hair follicles and leads to skin tumours called “cylindromas” forming and continually growing.
